IBDEI052 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6412,0)
 ;;=289.9^^53^518^13
 ;;^UTILITY(U,$J,358.3,6412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6412,1,3,0)
 ;;=3^289.9
 ;;^UTILITY(U,$J,358.3,6412,1,4,0)
 ;;=4^THROMBOCYTOSIS
 ;;^UTILITY(U,$J,358.3,6412,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,6413,0)
 ;;=401.9^^53^519^1
 ;;^UTILITY(U,$J,358.3,6413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6413,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,6413,1,4,0)
 ;;=4^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,6413,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,6414,0)
 ;;=401.1^^53^519^3
 ;;^UTILITY(U,$J,358.3,6414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6414,1,3,0)
 ;;=3^401.1
 ;;^UTILITY(U,$J,358.3,6414,1,4,0)
 ;;=4^HYPERTENSION,BENIGN
 ;;^UTILITY(U,$J,358.3,6414,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,6415,0)
 ;;=401.0^^53^519^2
 ;;^UTILITY(U,$J,358.3,6415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6415,1,3,0)
 ;;=3^401.0
 ;;^UTILITY(U,$J,358.3,6415,1,4,0)
 ;;=4^HYPERTENSION,ACCELERATED
 ;;^UTILITY(U,$J,358.3,6415,2)
 ;;=^73505
 ;;^UTILITY(U,$J,358.3,6416,0)
 ;;=227.0^^53^520^1
 ;;^UTILITY(U,$J,358.3,6416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6416,1,3,0)
 ;;=3^227.0
 ;;^UTILITY(U,$J,358.3,6416,1,4,0)
 ;;=4^ADRENAL NEOPLASM,BENIGN
 ;;^UTILITY(U,$J,358.3,6416,2)
 ;;=^267688
 ;;^UTILITY(U,$J,358.3,6417,0)
 ;;=194.0^^53^520^2
 ;;^UTILITY(U,$J,358.3,6417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6417,1,3,0)
 ;;=3^194.0
 ;;^UTILITY(U,$J,358.3,6417,1,4,0)
 ;;=4^ADRENAL NEOPLASM,MALIGNANT
 ;;^UTILITY(U,$J,358.3,6417,2)
 ;;=^267298
 ;;^UTILITY(U,$J,358.3,6418,0)
 ;;=255.10^^53^520^3
 ;;^UTILITY(U,$J,358.3,6418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6418,1,3,0)
 ;;=3^255.10
 ;;^UTILITY(U,$J,358.3,6418,1,4,0)
 ;;=4^ALDOSTERONISM
 ;;^UTILITY(U,$J,358.3,6418,2)
 ;;=^330019
 ;;^UTILITY(U,$J,358.3,6419,0)
 ;;=255.0^^53^520^4
 ;;^UTILITY(U,$J,358.3,6419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6419,1,3,0)
 ;;=3^255.0
 ;;^UTILITY(U,$J,358.3,6419,1,4,0)
 ;;=4^CUSHING'S SYNDROME
 ;;^UTILITY(U,$J,358.3,6419,2)
 ;;=^29802
 ;;^UTILITY(U,$J,358.3,6420,0)
 ;;=403.90^^53^520^6
 ;;^UTILITY(U,$J,358.3,6420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6420,1,3,0)
 ;;=3^403.90
 ;;^UTILITY(U,$J,358.3,6420,1,4,0)
 ;;=4^HTN RENAL w/o RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,6420,2)
 ;;=^334272
 ;;^UTILITY(U,$J,358.3,6421,0)
 ;;=403.91^^53^520^5
 ;;^UTILITY(U,$J,358.3,6421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6421,1,3,0)
 ;;=3^403.91
 ;;^UTILITY(U,$J,358.3,6421,1,4,0)
 ;;=4^HTN RENAL w/ RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,6421,2)
 ;;=^334242
 ;;^UTILITY(U,$J,358.3,6422,0)
 ;;=405.91^^53^520^7
 ;;^UTILITY(U,$J,358.3,6422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6422,1,3,0)
 ;;=3^405.91
 ;;^UTILITY(U,$J,358.3,6422,1,4,0)
 ;;=4^HTN RENOVASCULAR NOS
 ;;^UTILITY(U,$J,358.3,6422,2)
 ;;=^269634
 ;;^UTILITY(U,$J,358.3,6423,0)
 ;;=403.00^^53^520^9
 ;;^UTILITY(U,$J,358.3,6423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6423,1,3,0)
 ;;=3^403.00
 ;;^UTILITY(U,$J,358.3,6423,1,4,0)
 ;;=4^MAL HTN RENAL w/o RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,6423,2)
 ;;=^334270
 ;;^UTILITY(U,$J,358.3,6424,0)
 ;;=403.01^^53^520^8
 ;;^UTILITY(U,$J,358.3,6424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6424,1,3,0)
 ;;=3^403.01
 ;;^UTILITY(U,$J,358.3,6424,1,4,0)
 ;;=4^MAL HTN RENAL w/ RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,6424,2)
 ;;=^334240
 ;;^UTILITY(U,$J,358.3,6425,0)
 ;;=405.01^^53^520^10
 ;;^UTILITY(U,$J,358.3,6425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6425,1,3,0)
 ;;=3^405.01
 ;;^UTILITY(U,$J,358.3,6425,1,4,0)
 ;;=4^MAL HTN RENOVASCULAR
 ;;^UTILITY(U,$J,358.3,6425,2)
 ;;=^269628
 ;;^UTILITY(U,$J,358.3,6426,0)
 ;;=404.91^^53^521^1
 ;;^UTILITY(U,$J,358.3,6426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6426,1,3,0)
 ;;=3^404.91
 ;;^UTILITY(U,$J,358.3,6426,1,4,0)
 ;;=4^HTN HRT/REN w/ CHF,NOS
 ;;^UTILITY(U,$J,358.3,6426,2)
 ;;=^334249
 ;;^UTILITY(U,$J,358.3,6427,0)
 ;;=404.93^^53^521^2
 ;;^UTILITY(U,$J,358.3,6427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6427,1,3,0)
 ;;=3^404.93
 ;;^UTILITY(U,$J,358.3,6427,1,4,0)
 ;;=4^HTN HRT/REN w/ CHR&RF,NOS
 ;;^UTILITY(U,$J,358.3,6427,2)
 ;;=^334251
 ;;^UTILITY(U,$J,358.3,6428,0)
 ;;=404.90^^53^521^4
 ;;^UTILITY(U,$J,358.3,6428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6428,1,3,0)
 ;;=3^404.90
 ;;^UTILITY(U,$J,358.3,6428,1,4,0)
 ;;=4^HTN HRT/REN w/o CHF/RF,NOS
 ;;^UTILITY(U,$J,358.3,6428,2)
 ;;=^334275
 ;;^UTILITY(U,$J,358.3,6429,0)
 ;;=404.92^^53^521^3
 ;;^UTILITY(U,$J,358.3,6429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6429,1,3,0)
 ;;=3^404.92
 ;;^UTILITY(U,$J,358.3,6429,1,4,0)
 ;;=4^HTN HRT/REN w/ RENAL FAILURE,NOS
 ;;^UTILITY(U,$J,358.3,6429,2)
 ;;=^334250
 ;;^UTILITY(U,$J,358.3,6430,0)
 ;;=404.01^^53^521^5
 ;;^UTILITY(U,$J,358.3,6430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6430,1,3,0)
 ;;=3^404.01
 ;;^UTILITY(U,$J,358.3,6430,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ CHF
 ;;^UTILITY(U,$J,358.3,6430,2)
 ;;=^334243
 ;;^UTILITY(U,$J,358.3,6431,0)
 ;;=404.03^^53^521^6
 ;;^UTILITY(U,$J,358.3,6431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6431,1,3,0)
 ;;=3^404.03
 ;;^UTILITY(U,$J,358.3,6431,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ CHF&RF
 ;;^UTILITY(U,$J,358.3,6431,2)
 ;;=^334245
 ;;^UTILITY(U,$J,358.3,6432,0)
 ;;=404.00^^53^521^8
 ;;^UTILITY(U,$J,358.3,6432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6432,1,3,0)
 ;;=3^404.00
 ;;^UTILITY(U,$J,358.3,6432,1,4,0)
 ;;=4^MAL HTN HRT/REN w/o CHF&RF
 ;;^UTILITY(U,$J,358.3,6432,2)
 ;;=^334273
 ;;^UTILITY(U,$J,358.3,6433,0)
 ;;=404.02^^53^521^7
 ;;^UTILITY(U,$J,358.3,6433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6433,1,3,0)
 ;;=3^404.02
 ;;^UTILITY(U,$J,358.3,6433,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,6433,2)
 ;;=^334244
 ;;^UTILITY(U,$J,358.3,6434,0)
 ;;=466.0^^53^522^2
 ;;^UTILITY(U,$J,358.3,6434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6434,1,3,0)
 ;;=3^466.0
 ;;^UTILITY(U,$J,358.3,6434,1,4,0)
 ;;=4^BRONCHITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,6434,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,6435,0)
 ;;=682.8^^53^522^3
 ;;^UTILITY(U,$J,358.3,6435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6435,1,3,0)
 ;;=3^682.8
 ;;^UTILITY(U,$J,358.3,6435,1,4,0)
 ;;=4^CELLULITIS, SITE NEC
 ;;^UTILITY(U,$J,358.3,6435,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,6436,0)
 ;;=575.10^^53^522^4
 ;;^UTILITY(U,$J,358.3,6436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6436,1,3,0)
 ;;=3^575.10
 ;;^UTILITY(U,$J,358.3,6436,1,4,0)
 ;;=4^CHOLECYSTITIS,UNSP
 ;;^UTILITY(U,$J,358.3,6436,2)
 ;;=^23341
 ;;^UTILITY(U,$J,358.3,6437,0)
 ;;=372.39^^53^522^5
 ;;^UTILITY(U,$J,358.3,6437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6437,1,3,0)
 ;;=3^372.39
 ;;^UTILITY(U,$J,358.3,6437,1,4,0)
 ;;=4^CONJUNCTIVITIS NEC
 ;;^UTILITY(U,$J,358.3,6437,2)
 ;;=^87441
 ;;^UTILITY(U,$J,358.3,6438,0)
 ;;=110.1^^53^522^6
 ;;^UTILITY(U,$J,358.3,6438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6438,1,3,0)
 ;;=3^110.1
 ;;^UTILITY(U,$J,358.3,6438,1,4,0)
 ;;=4^DERMATOPHYTOSIS OF NAIL
 ;;^UTILITY(U,$J,358.3,6438,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,6439,0)
 ;;=562.11^^53^522^7
 ;;^UTILITY(U,$J,358.3,6439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6439,1,3,0)
 ;;=3^562.11
 ;;^UTILITY(U,$J,358.3,6439,1,4,0)
 ;;=4^DIVERTICULITIS
 ;;^UTILITY(U,$J,358.3,6439,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,6440,0)
 ;;=424.99^^53^522^8
 ;;^UTILITY(U,$J,358.3,6440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6440,1,3,0)
 ;;=3^424.99
 ;;^UTILITY(U,$J,358.3,6440,1,4,0)
 ;;=4^ENDOCARDITIS NEC
 ;;^UTILITY(U,$J,358.3,6440,2)
 ;;=^87573
 ;;^UTILITY(U,$J,358.3,6441,0)
 ;;=707.15^^53^522^9
 ;;^UTILITY(U,$J,358.3,6441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6441,1,3,0)
 ;;=3^707.15
 ;;^UTILITY(U,$J,358.3,6441,1,4,0)
 ;;=4^FOOT ULCER
 ;;^UTILITY(U,$J,358.3,6441,2)
 ;;=^322148
 ;;^UTILITY(U,$J,358.3,6442,0)
 ;;=558.9^^53^522^10
 ;;^UTILITY(U,$J,358.3,6442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6442,1,3,0)
 ;;=3^558.9
 ;;^UTILITY(U,$J,358.3,6442,1,4,0)
 ;;=4^GASTROENTERITIS
 ;;^UTILITY(U,$J,358.3,6442,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,6443,0)
 ;;=042.^^53^522^1
 ;;^UTILITY(U,$J,358.3,6443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6443,1,3,0)
 ;;=3^042.
 ;;^UTILITY(U,$J,358.3,6443,1,4,0)
 ;;=4^AIDS (SYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,6443,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,6444,0)
 ;;=V08.^^53^522^11
 ;;^UTILITY(U,$J,358.3,6444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6444,1,3,0)
 ;;=3^V08.
 ;;^UTILITY(U,$J,358.3,6444,1,4,0)
 ;;=4^HIV+ (ASYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,6444,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,6445,0)
 ;;=487.1^^53^522^12
 ;;^UTILITY(U,$J,358.3,6445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6445,1,3,0)
 ;;=3^487.1
 ;;^UTILITY(U,$J,358.3,6445,1,4,0)
 ;;=4^INFLUENZA
 ;;^UTILITY(U,$J,358.3,6445,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,6446,0)
 ;;=730.00^^53^522^13
 ;;^UTILITY(U,$J,358.3,6446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6446,1,3,0)
 ;;=3^730.00
 ;;^UTILITY(U,$J,358.3,6446,1,4,0)
 ;;=4^OSTEOMYELITIS
 ;;^UTILITY(U,$J,358.3,6446,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,6447,0)
 ;;=382.9^^53^522^14
 ;;^UTILITY(U,$J,358.3,6447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6447,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,6447,1,4,0)
 ;;=4^OTITIS MEDIA NOS
 ;;^UTILITY(U,$J,358.3,6447,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,6448,0)
 ;;=614.9^^53^522^15
 ;;^UTILITY(U,$J,358.3,6448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6448,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,6448,1,4,0)
 ;;=4^PELVIC INFLAMMATORY DISEASE
 ;;^UTILITY(U,$J,358.3,6448,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,6449,0)
 ;;=462.^^53^522^16
 ;;^UTILITY(U,$J,358.3,6449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6449,1,3,0)
 ;;=3^462.
 ;;^UTILITY(U,$J,358.3,6449,1,4,0)
 ;;=4^PHARYNGITIS
 ;;^UTILITY(U,$J,358.3,6449,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,6450,0)
 ;;=486.^^53^522^17
 ;;^UTILITY(U,$J,358.3,6450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6450,1,3,0)
 ;;=3^486.
